Wolverine Trading
WST icon

Wolverine Trading’s West Pharmaceutical WST Stock Holding History

Wolverine Trading’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,912
Closed -$1.76M – 5701
2025
Q1 		$1.76M Buy
7,912
+5,614
+244% +$1.55M ﹤0.01% 1727
2024
Q4 		$756K Buy
2,298
+1,647
+253% +$518K ﹤0.01% 2952
2024
Q3 		$202K Sell
651
-820
-56% -$251K ﹤0.01% 4084
2024
Q2 		$485K Sell
1,471
-611
-29% -$216K ﹤0.01% 2885
2024
Q1 		$824K Buy
2,082
+1,314
+171% +$486K ﹤0.01% 2370
2023
Q4 		$270K Buy
+768
New +$272K ﹤0.01% 3566
2022
Q2 		– Sell
-496
Closed -$161K – 5875
2022
Q1 		$207K Sell
496
-3,129
-86% -$1.22M ﹤0.01% 4385
2021
Q4 		$1.71M Buy
3,625
+2,668
+279% +$1.15M ﹤0.01% 2035
2021
Q3 		$414K Buy
957
+54
+6% +$22.8K ﹤0.01% 4223
2021
Q2 		$325K Buy
+903
New +$298K ﹤0.01% 4317
2020
Q3 		– Sell
-3,025
Closed -$801K – 5261
2020
Q2 		$666K Buy
+3,025
New +$594K ﹤0.01% 2426
2019
Q4 		– Sell
-5,320
Closed -$749K – 5300
2019
Q3 		$749K Buy
5,320
+788
+17% +$108K ﹤0.01% 2220
2019
Q2 		$567K Sell
4,532
-9,047
-67% -$1.07M ﹤0.01% 2585
2019
Q1 		$1.5M Buy
+13,579
New +$1.41M ﹤0.01% 1761
2017
Q3 		– Sell
-2,121
Closed -$192K – 5156
2017
Q2 		$200K Buy
+2,121
New +$195K ﹤0.01% 3599
2016
Q3 		– Sell
-3,554
Closed -$264K – 5189
2016
Q2 		$264K Buy
+3,554
New +$259K ﹤0.01% 2956

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Wolverine Trading's WST Position: Q2 2025 in Review

Wolverine Trading sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 7,912 shares — an estimated $1.76M sold.

Wolverine Trading first reported a position in WST in Q2 2016 and held it in 16 quarters. The position peaked at $1.76M in Q1 2025. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Wolverine Trading reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 7,912 West Pharmaceutical shares in Q2 2025, an estimated $1.76M.
  • Wolverine Trading first reported a position in West Pharmaceutical in Q2 2016 and held it in 16 quarters.
  • Wolverine Trading's West Pharmaceutical position peaked at $1.76M in Q1 2025.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.